Karin Heidemann
Direttore Tecnico/Scientifico/R&S presso CHAMPIONS ONCOLOGY, INC.
Posizioni attive di Karin Heidemann
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CHAMPIONS ONCOLOGY, INC. | Direttore Tecnico/Scientifico/R&S | 01/09/2019 | - |
Storia della carriera di Karin Heidemann
Precedenti posizioni note di Karin Heidemann
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Rockland Immunochemicals, Inc.
 Rockland Immunochemicals, Inc. BiotechnologyHealth Technology Rockland Immunochemicals, Inc. is a biotech company that was founded in 1962. The private company is based in Limerick, PA and has subsidiaries in the United States and Germany. The company specializes in manufacturing cutting-edge tools for basic, applied, and clinical research. The company offers custom anti-id antibodies for specific therapeutic development and tissue powders that can be used as a specific adsorbent to remove unwanted reactivities or as source material. The CEO of Rockland Immunochemicals is James Fendrick. | Corporate Officer/Principal | 01/03/2017 | 01/09/2019 |
Formazione di Karin Heidemann
| Universität zu Köln | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
| Germania | 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CHAMPIONS ONCOLOGY, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Rockland Immunochemicals, Inc.
Rockland Immunochemicals, Inc. BiotechnologyHealth Technology Rockland Immunochemicals, Inc. is a biotech company that was founded in 1962. The private company is based in Limerick, PA and has subsidiaries in the United States and Germany. The company specializes in manufacturing cutting-edge tools for basic, applied, and clinical research. The company offers custom anti-id antibodies for specific therapeutic development and tissue powders that can be used as a specific adsorbent to remove unwanted reactivities or as source material. The CEO of Rockland Immunochemicals is James Fendrick. | Health Technology |
- Borsa valori
- Insiders
- Karin Heidemann
- Esperienza
